All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Evaluation of Female Orgasmic Disorder

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11240%2F17%3A10361087" target="_blank" >RIV/00216208:11240/17:10361087 - isvavai.cz</a>

  • Result on the web

    <a href="http://dx.doi.org/10.1007/978-3-319-52539-6_14" target="_blank" >http://dx.doi.org/10.1007/978-3-319-52539-6_14</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1007/978-3-319-52539-6_14" target="_blank" >10.1007/978-3-319-52539-6_14</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Evaluation of Female Orgasmic Disorder

  • Original language description

    An important review paper on disorders of orgasm in women noted that orgasm disorder is second only to hypoactive sexual desire disorder in women&apos;s sexual disorder prevalence. A recent meta-analysis of studies (limited to English language publications published between 2000 and 2014) on the prevalence of female sexual dysfunction among premenopausal women reported an overall female orgasmic disorder prevalence of 20.9%, increasing to 25.7% when a statistical model meant to adjust for the quality of studies was applied to the analysis [2]. That meta-analysis noted substantial variability in the diagnostic criteria used for ascertaining female orgasmic disorder (including variability in the qualifying period for prevalence) and also reported that prevalence of female orgasmic disorder in Africa was highest, followed by Asia and the Middle East, with the lowest nominal prevalence in Europe and the non-European West. Optimal nationally representative sampling was used in only a minority of studies included in the meta-analyses, which raises issues of selection bias and participation bias in many studies in the review, as well as other studies pertaining to sexual function and sexual dysfunction that were not part of the review. Interestingly, the authors of the metaanalysis concluded that studies of the prevalence of orgasmic dysfunction funded by pharmaceutical companies tended to be of higher quality than other studies. The meta-analysis did not differentiate between orgasm triggers (specifics of the sexual behavior intended to induce orgasm; see discussion of the Sexual Behavior Questionnaire in the Scales section for a list of major orgasm triggers), and unfortunately many, perhaps most, studies also fail to differentiate between orgasm triggers. As should become clear in this chapter, there are substantial psychological, interpersonal, and physiological differences between women&apos;s various sexual behaviors and corresponding orgasm triggers.

  • Czech name

  • Czech description

Classification

  • Type

    C - Chapter in a specialist book

  • CEP classification

  • OECD FORD branch

    30215 - Psychiatry

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2017

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Book/collection name

    The Textbook of Clinical Sexual Medicine

  • ISBN

    978-3-319-52538-9

  • Number of pages of the result

    15

  • Pages from-to

    203-217

  • Number of pages of the book

    636

  • Publisher name

    Springer

  • Place of publication

    Cham

  • UT code for WoS chapter